EN DE

Heranba Industries Limited (HERANBA) Fair Value & Analysis

Basic Materials · IN · Market cap ₹7.4B

HI Heranba Industries Limited HERANBA · NSE
Price₹169.76
Fair Value₹74.54
Upside-56.1%
Quality37/100
Watch Heranba Industries Limited for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Loss-making · -4.8% net margin
Low debt · negative free cash flow
Trails peers (1/10)
Narrow moat 2/100
Evidence: Low Range ₹15.72 – ₹161.06 Share as image

Fair value as of: Aug 13, 2026

From 4 valuation models · updated 3 days ago

Fair value updated Aug 13, 2026, revised from ₹37.27 to ₹74.54 (+100.0%) since Aug 6, 2026. Share price −6.0% over the past month.

Below-average quality, and screening another 56% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (₹161.06). The favourable scenario is already priced in.
  • Weak quality (37/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • The model range is unusually wide (₹15.72 to ₹161.06). The outcome hinges heavily on assumptions, so read the point estimate with caution.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

₹830.53 ₹157.52 Fair Value ₹74.54 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range ₹157.52 – ₹830.53 · fair‑value band ₹15.72 – ₹161.06 · the ₹169.76 price screens above the ₹74.54 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Heranba Industries Limited (HERANBA) currently trades at ₹169.76, while our model-based Fair Value estimate is ₹74.54, implying the stock looks roughly 56.1% overvalued today. The Quality Score stands at 37/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Over the trailing twelve months, Heranba Industries Limited generated revenue of ₹15.9B at a net margin of -4.8%. Revenue declined 4.6% year over year. It earns a return on equity of -9.6%. Net debt stands at ₹5.4B. Fundamentals as of Aug 13, 2026

Our scenario range runs from ₹15.72 (bear case) to ₹161.06 (bull case); at ₹169.76, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 58% below its 52-week high and 9% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -17% fair-value upside, at -56%, HERANBA screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Gordon GGM ₹8.78 ₹17.49 ₹26.49 70
DDM Multi-Stage ₹8.78 ₹15.12 ₹18.47 61
EV/EBITDA ₹117.16 ₹160.42 ₹203.68 54
All 4 models by family
Dividend Discount
Gordon GGM ₹8.78 ₹17.49 ₹26.49 70
DDM Multi-Stage ₹8.78 ₹15.12 ₹18.47 61
Multiples
EV/EBITDA ₹117.16 ₹160.42 ₹203.68 54
Asset-Based
NCAV (Graham) ₹95.18 ₹127.55 ₹190.37 50

Widest divergence: Multiples (₹160.42) versus Dividend Discount (₹15.12). Highest evidence: Gordon GGM (70).

Notify me when HERANBA reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) ₹15.9B
Revenue growth (YoY) -4.6%
Net margin -4.8%
Return on equity -9.6%
Free cash flow −₹2.3B FY2026
Operating margin -15.3%
More key figures
EPS (TTM) ₹-19.10
EPS growth (YoY) -63.5%
Net debt ₹5.4B FY2026

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 37/100

Of which business quality 39 · Market factors (momentum, volatility) 30

Profitability 18
Margins and returns on capital today
Quality Growth 30
Are margins and returns improving?
Cashflow 30
Earnings quality: real cash, not paper profit
Fin. Strength 38
Balance sheet, leverage, solvency risk
Investment 61
Disciplined investing over empire-building
Low Volatility 75
Calm price path (market factor)
Momentum 16
Price trend over the last 3–12 months (market factor)
52W Momentum 3
Distance to the 52-week high (market factor)
Net Issuance 80
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Heranba Industries Limited manufactures and sells various agrochemicals in India and internationally. It offers intermediates, such as cypermethric acid chloride (CMAC), high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benzaldehyde and benzyl alcohol, and NPBR; and insecticides, including cypermethrin, deltamethrin, alpha …

Full company description

Heranba Industries Limited manufactures and sells various agrochemicals in India and internationally. It offers intermediates, such as cypermethric acid chloride (CMAC), high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benzaldehyde and benzyl alcohol, and NPBR; and insecticides, including cypermethrin, deltamethrin, alpha cypermethrin, tolfenpyrad, lambda cyhalothrin, permethrin, profenophos, dinotefuran, temephos, theta cypermethrin, diflubenzuron, ethion, methamidophos, thiophanate-methyl, and bifenthrin. The company also provides fungicides comprising tricyclazole, hexaconazole, tebuconazole, thifluzamide, propiconazole, picoxystrobin, and dodine; herbicides consisting of bispyribac sodium, clodinafop, tembotorine, and pendimethalin; and plant growth regulators. In addition, it offers formulations, such as emulsifiable concentrate, capsule suspension, suspension concentrate, oil dispersion, concentrated aqueous emulsions, wettable powder, suspoemulsion, water dispersible granule, ZC formulation, soluble liquid, flowable concentration, and soluble powder. The company was formerly known as Heranba Industrial Chemicals Limited and changed its name to Heranba Industries Limited in July 1996. Heranba Industries Limited was incorporated in 1992 and is based in Mumbai, India.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Heranba Industries Limited reported revenue of ₹15.9B in FY2026 versus ₹14.3B in FY2022, a compound +2.7%/yr. Reported net income was −₹764M in FY2026.

Growth Quality 25/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2026)
₹15.9B
Latest YoY
+12.5%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.7%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.8%
Avg. growth/yr (12Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+11.0%
Revenue +2.7%/yr
FY22 ₹14.3B
FY23 ₹13.1B
FY24 ₹12.5B
FY25 ₹14.2B
FY26 ₹15.9B
Net income
FY22 ₹1.9B
FY23 ₹1.0B
FY24 ₹349M
FY25 ₹30.7M
FY26 −₹764M
Character of growth · EPS growth decomposed (2015-2026) +0.6 % p.a.
Revenue per share +11.2 pp

of which total revenue +11.2 pp · buybacks/dilution +0.0 pp

EBIT margin +8.0 pp
Tax rate −1.2 pp
Residual (interest, one-offs) −17.4 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

HERANBA screens 56% overvalued. Compare with Corteva, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Heranba Industries Limited Fair Value". https://www.fairvalue-calculator.com/stock/HERANBA

Peer Group

Agricultural Inputs · 178 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 37 · Bottom 25%
Fair Value upside −56% · Bottom 25%
Return on assets -1% · Bottom 25%
Net margin (TTM) -5% · Bottom 25%
Operating margin (TTM) -15% · Bottom 25%
Revenue growth -5% · Bottom 25%
Dividend yield (TTM) 0.5% · Bottom 25%
Debt / equity 0.11× · Higher than median

Valuation Multiples vs Agricultural Inputs median · lower = cheaper

EV/EBITDA 0.8× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 24
FUTURE 0 · sector 41
PAST 0 · sector 24
HEALTH 95 · sector 97
DIVIDEND 11 · sector 41

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Corteva, Inc CTVA $76.22 $27.81 -64%
Nutrien Ltd NTR C$93.60 C$81.69 -13%
Qinghai Salt Lake Industry Co 000792 ¥27.65 ¥21.26 -23%
CF Industries Holdings CF $120.01 $161.00 +34%
SABIC Agri-Nutrients Company 2020 122.90 SAR 127.31 SAR +4%
Yara International ASA YAR kr 418.10 kr 67.25 -84%
Yunnan Yuntianhua Co 600096 ¥29.82 ¥42.12 +41%
Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 ¥45.86 ¥38.01 -17%
Coromandel International Limited COROMANDEL ₹2,089 ₹1,129 -46%
UPL Limited UPL ₹570.50 ₹387.06 -32%

Compare Heranba Industries Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Heranba Industries Limited (HERANBA) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of ₹74.54 versus a price of ₹169.76, about −56% (overvalued).
What is the fair value of HERANBA?
Our model-based fair value for Heranba Industries Limited is ₹74.54 (as of Aug 13, 2026), built from audited fundamentals. The current price is ₹169.76.
What is the quality score of HERANBA?
Heranba Industries Limited has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Heranba Industries Limited (HERANBA)?
Heranba Industries Limited reported trailing-twelve-month revenue of about ₹15.9B (latest available figure, as of Aug 13, 2026).
What is the net profit margin of HERANBA?
The net profit margin of Heranba Industries Limited is about -4.8%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Heranba Industries Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.